Biocon Biologics Extends Lifeline—Malaysia Renews Insulin Pact, Expands Access to Affordable Care

Unknown Apr 02, 2026 950 Views

Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has secured a six-month extension to its existing insulin supply contract with the Malaysian Ministry of Health (MoH), reinforcing its decade-long commitment to affordable diabetes care in the region. The extension, effective April 29 to October 2...